Diana Mendes

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 10

Top Topics

Klebsiella Pneumoniae

Respiratory Syndrome Coronavirus

Cross Sectional

Top Venues

Expert review of vaccines

Journal of medical economics

Expert review of pharmacoeconomics & outcomes research

This page only lists publications with an associated author ORCID identifier.

Publications

Diana Mendes, Ruth Chapman, Elena Aruffo, Peter Gal, Jennifer L Nguyen, Libby Hamson, Manuela di Fusco, Carole Czudek, Jingyan Yang
Public health impact of UK COVID-19 booster vaccination programs during Omicron predominance. Expert review of vaccines (2023)
Michele Wilson, Aaron Lucas, Diana Mendes, Andrew Vyse, Boglarka Mikudina, Carole Czudek, Gillian Frances Ellsbury, Johnna Perdrizet
Estimating the Cost-Effectiveness of Switching to Higher-Valency Pediatric Pneumococcal Conjugate Vaccines in the United Kingdom. Vaccines 11 (7) (2023)
Diana Mendes, Ruth Chapman, Elena Aruffo, Peter Gal, Jennifer L Nguyen, Libby Hamson, Manuela di Fusco, Carole Czudek, Jingyan Yang
Public health impact of UK COVID-19 booster vaccination programs during Omicron predominance. Expert review of vaccines 22 (1) (2023)
Diana Mendes, Ruth Chapman, Elena Aruffo, Peter Gal, Jennifer L Nguyen, Libby Hamson, Manuela di Fusco, Carole Czudek, Jingyan Yang
Public health impact of UK COVID-19 booster vaccination programs during Omicron predominance. Expert review of vaccines 22 (1) (2023)
Diana Mendes, Ruth Chapman, Elena Aruffo, Peter Gal, Jennifer L Nguyen, Libby Hamson, Manuela di Fusco, Carole Czudek, Jingyan Yang
Public health impact of UK COVID-19 booster vaccination programs during Omicron predominance. Expert review of vaccines 22 (1) (2023)
Diana Mendes, Ahuva Averin, Mark Atwood, Reiko Sato, Andrew Vyse, James Campling, Derek Weycker, Mary P E Slack, Gillian F Ellsbury, Tendai Mugwagwa
Cost-effectiveness of using a 20-valent pneumococcal conjugate vaccine to directly protect adults in England at elevated risk of pneumococcal disease. Expert review of pharmacoeconomics & outcomes research 22 (8) (2022)
James Campling, Hannah F Wright, Gillian C Hall, Tendai Mugwagwa, Andrew Vyse, Diana Mendes, Mary P E Slack, Gillian F Ellsbury
Hospitalization costs of adult community-acquired pneumonia in England. Journal of medical economics 25 (1) (2022)
Diana Mendes, Ruth Chapman, Peter Gal, Jessica Atwell, Jennifer L Nguyen, Libby Hamson, Manuela di Fusco, Carole Czudek, Jingyan Yang
Public health impact of booster vaccination against COVID-19 in the UK during Delta variant dominance in autumn 2021. Journal of medical economics 25 (1) (2022)
Tendai Mugwagwa, Ahuva Averin, Mark Atwood, Reiko Sato, Andrew Vyse, James Campling, Derek Weycker, Mary P E Slack, Gillian F Ellsbury, Diana Mendes
Public health and budgetary impact of 20-valent pneumococcal conjugate vaccine for adults in England. Expert review of vaccines 21 (9) (2022)
Diana Mendes, Ruth Chapman, Elena Aruffo, Peter Gal, Jennifer L Nguyen, Libby Hamson, Manuela di Fusco, Carole Czudek, Jingyan Yang
Public health impact of UK COVID-19 booster vaccination programs during Omicron predominance. Expert review of vaccines (2022)